Our long-term goal
We are on a mission to accelerate the translation and clinical application of novel imaging biomarkers to improve monitoring of high-risk pregnancies and to develop windows of therapeutic opportunity aimed at repairing and restoring fetal health.
The Developing Brain Institute at Children’s National will serve as the magnetic resonance image coordinating center for the four-year Outcomes of Babies with Opioid Exposure (OBOE) study.
We are studying whether a prenatal maternal Cognitive Behavioral Therapy (CBT) intervention helps to improve maternal and infant outcomes for pregnant women carrying fetuses diagnosed with CHD.
Project MAGIC uses novel magnetic resonance spectroscopy to measure GABA concentrations in the developing brains of small preterm infants.
In Project PEPERONI, we use cutting-edge imaging to monitor how well the placenta works.
In Project PROTECT, we use cutting-edge imaging to monitor early brain development to pick up early signs if it veers off track.
In this research study, our team will leverage its mastery of sophisticated MRI studies to identify risks of COVID-19-related maternal distress.